Phenotype expression in women with CMT1X

Charcot‐Marie‐Tooth disease type 1X (CMT1X) is the second most common inherited peripheral neuropathy. Women with CMT1X typically have a less severe phenotype than men, perhaps because of X‐inactivation patterns. Our objective was to determine the phenotype of women with CMT1X and whether X‐inactivation patterns in white blood cells (WBCs) differ between females with CMT1X and controls. Thirty‐one women with CMT1X were evaluated using the CMT neuropathy score (CMTNS) and the CMT symptom score in cross‐sectional and longitudinal analyses. Lower scores correspond to less disability. WBCs were analyzed for X‐inactivation pattern by androgen receptor X‐inactivation assay in 14 patients and 23 controls. The 31 women's mean CMTNS was 8.35. Two‐thirds of the cohort had a mild CMTNS (mean 4.85) and one‐third had a moderate CMTNS (mean 14.73). Three patients had a CMTNS of 0. The pattern of X‐inactivation did not differ between the affected and control groups. Women with CMT1X presented with variable impairment independent of age, type of mutation, or location of mutation. No evidence supported the presence of a gap junction beta‐1 (GJB1) mutation affecting the pattern of X‐inactivation in blood. Further studies are planned to determine whether X‐inactivation is the mechanism for CMT1X females' variable phenotypes.

[1]  A. Brice,et al.  Clinical, electrophysiological and molecular genetic characteristics of 93 patients with X-linked Charcot-Marie-Tooth disease. , 2001, Brain : a journal of neurology.

[2]  K. Ørstavik X chromosome inactivation in clinical practice , 2009, Human Genetics.

[3]  M. Shy,et al.  Charcot‐marie‐tooth disease subtypes and genetic testing strategies , 2011, Annals of neurology.

[4]  S. Scherer,et al.  CMT1X phenotypes represent loss of GJB1 gene function , 2007, Neurology.

[5]  K. Fischbeck,et al.  Connexin mutations in X-linked Charcot-Marie-Tooth disease. , 1993, Science.

[6]  Skewed X inactivation in healthy individuals and in different diseases , 2006 .

[7]  C. Stoll,et al.  SIMPLE mutation analysis in dominant demyelinating Charcot‐Marie‐Tooth disease: three novel mutations , 2006, Journal of the peripheral nervous system : JPNS.

[8]  K. Ørstavik Skewed X inactivation in healthy individuals and in different diseases. , 2006, Acta paediatrica (Oslo, Norway : 1992). Supplement.

[9]  A. Sharp,et al.  Age- and tissue-specific variation of X chromosome inactivation ratios in normal women , 2000, Human Genetics.

[10]  J. Lupski,et al.  Practice Parameter: Evaluation of distal symmetric polyneuropathy: Role of autonomic testing, nerve biopsy, and skin biopsy (an evidence-based review) , 2009, Neurology.

[11]  Jun Yu Li,et al.  Reliability and validity of the CMT neuropathy score as a measure of disability , 2005, Neurology.

[12]  D. Linch,et al.  Tissue specificity of X-chromosome inactivation patterns. , 1994, Blood.

[13]  W. Brown,et al.  Genotype/phenotype correlations in X-linked dominant Charcot-Marie-Tooth disease. , 1999, Annals of the New York Academy of Sciences.

[14]  K. Fischbeck,et al.  A Unique Mutation in Connexin32 Associated with Severe, Early Onset CMTX in a Heterozygous Female , 1999, Annals of the New York Academy of Sciences.

[15]  H. Willard,et al.  X chromosome-inactivation patterns of 1,005 phenotypically unaffected females. , 2006, American journal of human genetics.

[16]  J. Lupski,et al.  Practice Parameter: Evaluation of distal symmetric polyneuropathy: Role of laboratory and genetic testing (an evidence-based review) , 2009, Neurology.

[17]  X. Estivill,et al.  Estimation of the Mutation Frequencies in Charcot-Marie-Tooth Disease Type 1 and Hereditary Neuropathy with Liability to Pressure Palsies: A European Collaborative Study , 1996, European journal of human genetics : EJHG.

[18]  M. Leppert,et al.  Heritability of X chromosome--inactivation phenotype in a large family. , 1996, American journal of human genetics.

[19]  H. Zoghbi,et al.  Methylation of HpaII and HhaI sites near the polymorphic CAG repeat in the human androgen-receptor gene correlates with X chromosome inactivation. , 1992, American journal of human genetics.

[20]  J. Belmont Genetic control of X inactivation and processes leading to X-inactivation skewing. , 1996, American journal of human genetics.

[21]  K. Arimura,et al.  Clinical phenotype in X-linked Charcot-Marie-Tooth disease with an entire deletion of the connexin 32 coding sequence , 2001, Journal of the Neurological Sciences.